Main menu

Nanopore sequencing for clinical genetics: From critical care to complex genomic signatures

  • Published on:

Debarshi Mustafi (Seattle Children’s Hospital, USA) discusses how the capabilities of nanopore sequencing could translate into clinical insight in the future. Using examples from inherited retinal disease and retinoblastoma, he will illustrate how long nanopore reads can resolve difficult structural and noncoding variants, phase haplotypes, determine parental origin, and generate methylation data alongside genetic information.

This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.

Authors: Debarshi Mustafi (Seattle Children's Hospital)

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditation
Japanese flag